tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

EyePoint Pharmaceuticals Inc

EYPT
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
0.380USD
+0.003+0.80%
์ข…๊ฐ€ย 10-29 16:00๏ผˆET๏ผ‰
32.76M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

EyePoint Pharmaceuticals Inc

0.380
+0.003+0.80%
๊ฐœ์š”
๋‰ด์Šค & ๋ถ„์„
๊ธˆ์œต
์ฃผ์‹ ์ ์ˆ˜
๊ธฐ์ˆ 
์˜ˆ์ƒ
์†Œ์œ ๊ถŒ
๋ฐฐ๋‹น๊ธˆ
ํ”„๋กœํ•„
ํ† ๋ก 
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

๊ฐœ์š”

๋‰ด์Šค & ๋ถ„์„

๊ธˆ์œต

์ฃผ์‹ ์ ์ˆ˜

๊ธฐ์ˆ 

์˜ˆ์ƒ

์†Œ์œ ๊ถŒ

๋ฐฐ๋‹น๊ธˆ

ํ”„๋กœํ•„

ํ† ๋ก 

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ์ˆ˜์ต์žฌ๋ฌด์ œํ‘œ๊ธฐ์—… ๊ฐ€์น˜ ํ‰๊ฐ€์œ„ํ—˜ ์š”์†Œ

EYPT ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด EyePoint Pharmaceuticals Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ํ•ต์‹ฌ ์žฌ๋ฌด ๋น„์œจ
์‹œ๊ฐ€์ด์•ก
32.76M
๋ฐฐ๋‹น ์ˆ˜์ต๋ฅ 
0.00
P/E TTM
-0.11
์ฃผ๋‹น์ˆœ์ด์ต
-3.51
์ˆ˜์ต
31.37M
์ˆœ์ด์ต
-130.87M
ROE
-102.71%
ROA
-83.47%
EyePoint Pharmaceuticals Inc ์‹ค์  ๋ฐœํ‘œ์ผ๎˜
์ตœ์‹  ์ถœ์‹œ
Aug 5, 2026
EPS / ์˜ˆ์ƒ
-1.09/-0.95
์ˆ˜์ต / ์˜ˆ์ƒ
507.00K/406.86K

์žฌ๋ฌด์ œํ‘œ ์š”์•ฝ

๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
์žฌ๋ฌด ์ง€ํ‘œ
EPS
-28.45%-1.09
-52.27%-0.99
-26.92%-0.81
-57.86%-0.85
-46.68%-0.85
-17.05%-0.65
-91.79%-0.64
-63.93%-0.54
5.02%-0.58
1.97%-0.55
71.28%-0.33
---0.33
---0.61
---0.56
---1.16
---1.58
----
----
----
----
์ˆ˜์ต
-90.49%507.00K
-97.15%696.00K
-94.65%620.00K
-90.82%966.00K
-43.73%5.33M
109.29%24.45M
-17.39%11.59M
-30.77%10.52M
4.09%9.48M
52.08%11.68M
33.18%14.03M
51.84%15.20M
-21.27%9.11M
-17.33%7.68M
-8.76%10.53M
10.52%10.01M
28.31%11.56M
26.92%9.29M
61.88%11.54M
-42.28%9.06M
์ˆœ์ด์ต
-58.97%-94.47M
-87.70%-84.83M
-63.31%-67.61M
-103.44%-59.73M
-92.78%-59.43M
-54.33%-45.20M
-193.63%-41.40M
-132.80%-29.36M
-34.49%-30.83M
-38.37%-29.28M
67.55%-14.10M
31.53%-12.61M
-18.11%-22.92M
-0.90%-21.16M
-123.61%-43.45M
-10.33%-18.42M
-93.87%-19.41M
-70.81%-20.98M
-25.62%-19.43M
-339.23%-16.70M
์ˆœ์ด์ต๋ฅ 
-1572.17%-18633.14%
-6494.66%-12188.51%
-2952.33%-10904.68%
-2116.36%-6183.44%
-242.58%-1114.31%
26.26%-184.82%
-255.46%-357.26%
-236.28%-278.99%
-29.21%-325.27%
9.01%-250.63%
75.64%-100.51%
---82.96%
---251.73%
---275.47%
---412.53%
---190.48%
----
----
----
----
์ด ์ด์ต๋ฅ 
3.19%100.00%
-75.04%24.14%
-57.49%39.52%
-72.73%25.36%
13.72%96.91%
3.43%96.71%
0.08%92.96%
0.99%93.01%
6.10%85.22%
2.00%93.50%
41.42%92.89%
--92.09%
--80.32%
--91.67%
--65.68%
--78.10%
----
----
----
----
๋ถ€์ฑ„๋น„์œจ
----
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--0.00%
--22.42%
--22.08%
--18.05%
----
----
----
----
์†์ต๊ณ„์‚ฐ์„œ๎˜
์ˆ˜์ต
-90.49%507.00K
-97.15%696.00K
-94.65%620.00K
-90.82%966.00K
-43.73%5.33M
109.29%24.45M
-17.39%11.59M
-30.77%10.52M
4.09%9.48M
52.08%11.68M
33.18%14.03M
51.84%15.20M
-21.27%9.11M
-17.33%7.68M
-8.76%10.53M
10.52%10.01M
28.31%11.56M
26.92%9.29M
61.88%11.54M
-42.28%9.06M
์˜์—… ์ด์ต
-56.49%-97.38M
-78.61%-87.23M
-55.50%-70.34M
-89.40%-62.02M
-80.13%-62.23M
-46.57%-48.84M
-176.62%-45.24M
-127.45%-32.75M
-51.78%-34.55M
-54.59%-33.32M
29.01%-16.35M
21.74%-14.40M
-18.45%-22.76M
-17.88%-21.55M
-27.62%-23.04M
-20.15%-18.40M
-75.03%-19.22M
-67.21%-18.28M
-41.71%-18.05M
-682.47%-15.31M
์ˆœ์ด์ต
-58.97%-94.47M
-87.70%-84.83M
-63.31%-67.61M
-103.44%-59.73M
-92.78%-59.43M
-54.33%-45.20M
-193.63%-41.40M
-132.80%-29.36M
-34.49%-30.83M
-38.37%-29.28M
67.55%-14.10M
31.53%-12.61M
-18.11%-22.92M
-0.90%-21.16M
-123.61%-43.45M
-10.33%-18.42M
-93.87%-19.41M
-70.81%-20.98M
-25.62%-19.43M
-339.23%-16.70M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
-28.82%188.82M
-23.70%249.50M
-14.26%328.65M
-19.53%216.11M
-10.06%265.25M
2.92%326.98M
11.17%383.31M
78.84%268.55M
76.48%294.93M
117.52%317.71M
99.53%344.80M
-21.83%150.16M
-18.82%167.12M
-33.50%146.06M
-27.31%172.81M
35.50%192.10M
35.59%205.87M
37.83%219.63M
276.67%237.75M
197.90%141.78M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
26.43%41.94M
-10.12%37.46M
-24.51%37.02M
-38.32%30.09M
-46.58%33.17M
-33.40%41.68M
-22.47%49.05M
-23.64%48.79M
-9.89%62.10M
129.72%62.58M
83.17%63.26M
86.52%63.90M
106.40%68.92M
-14.79%27.24M
45.98%34.54M
71.86%34.26M
105.48%33.39M
137.86%31.97M
58.91%23.66M
54.20%19.93M
์ด ์ž์‚ฐ
-24.23%228.19M
-20.51%288.22M
-13.02%364.00M
-16.36%251.69M
-7.12%301.15M
10.12%362.56M
17.82%418.46M
88.02%300.92M
84.59%324.25M
112.98%329.25M
96.93%355.18M
-27.41%160.04M
-24.75%175.66M
-36.79%154.59M
-31.52%180.36M
31.05%220.49M
30.54%233.43M
30.68%244.56M
187.16%263.37M
119.10%168.25M
๋ถ€์ฑ„ ์ด๊ณ„
12.05%61.78M
-10.01%57.74M
-29.38%57.88M
-37.32%51.51M
-42.53%55.14M
-19.10%64.17M
-7.76%81.96M
-18.97%82.18M
-18.96%95.94M
4.08%79.31M
5.80%88.86M
20.54%101.42M
44.26%118.39M
-1.97%76.20M
6.32%83.99M
11.44%84.14M
14.05%82.07M
8.82%77.74M
7.95%78.99M
9.11%75.50M
์ž๋ณธ ์ด๊ณ„
-32.36%166.41M
-22.76%230.47M
-9.03%306.11M
-8.48%200.18M
7.75%246.01M
19.39%298.40M
26.35%336.50M
273.13%218.73M
298.70%228.31M
218.83%249.93M
176.36%266.32M
-57.01%58.62M
-62.17%57.26M
-53.01%78.39M
-47.73%96.37M
47.01%136.35M
41.64%151.37M
44.17%166.82M
894.44%184.38M
1121.33%92.75M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
0.39%-62.35M
-51.64%-80.55M
-81.45%-65.05M
-52.08%-59.35M
-210.18%-62.59M
-70.41%-53.12M
-55.13%-35.85M
-156.70%-39.03M
-135.39%-20.18M
-85.16%-31.17M
-83.58%-23.11M
-15.74%-15.20M
398.19%57.02M
16.48%-16.84M
24.48%-12.59M
-68.69%-13.14M
-81.38%-19.12M
-33.51%-20.16M
-382.75%-16.67M
-785.48%-7.79M
์ˆœํˆฌ์ž
55.37%75.10M
49.41%59.05M
22.19%-74.67M
241.97%55.38M
130.14%48.34M
89.97%39.52M
-103.53%-95.96M
1041.63%16.20M
-1291.02%-160.40M
-35.16%20.81M
-243.23%-47.15M
-127.42%-1.72M
112325.00%13.47M
156.85%32.09M
199.85%32.92M
4887.79%6.27M
52.00%-12.00K
---56.44M
-17069.27%-32.97M
-2.34%-131.00K
์ˆœ์žฌ๋ฌดํ™œ๋™
8300.00%19.99M
-174.87%-2.61M
10.07%166.96M
-37.75%7.40M
-27.66%238.00K
-926.96%-951.00K
-30.57%151.69M
14.78%11.89M
100.90%329.00K
102.25%115.00K
376798.28%218.49M
11163.04%10.36M
-13181.88%-36.66M
-1042.63%-5.12M
-100.05%-58.00K
4700.00%92.00K
27.56%-276.00K
-100.41%-448.00K
935.46%108.52M
-100.04%-2.00K

์ˆ˜์ต๎˜

์‚ฌ์—…๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ง€์—ญ๋ณ„

์ฃผ๊ธฐ:
๋ฐ์ดํ„ฐ ์—†์Œ

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

EyePoint Pharmaceuticals Inc์˜ ์ด์ˆ˜์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์€ 31.37M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 43.27M์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 328.65M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -14.26์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, EyePoint Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์€ 364.00M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -13.02์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, EyePoint Pharmaceuticals Inc์˜ ์ด๋ถ€์ฑ„๋Š” 57.88M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -29.38์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, EyePoint Pharmaceuticals Inc์˜ ์ด์ž๋ณธ์€ 306.11M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -9.03์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, EyePoint Pharmaceuticals Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -243.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -66.90์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, EyePoint Pharmaceuticals Inc์˜ ์ˆœํˆฌ์ž๋Š” 68.58M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 131.26์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, EyePoint Pharmaceuticals Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 173.65M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 5.87์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -3.17์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -36.22์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -231.96M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -77.25์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ˆœ์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต๋ฅ ์€ -739.42์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -144.49์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ๋งค์ถœ์ด์ด์ต๋ฅ ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ๋งค์ถœ์ด์ด์ต๋ฅ ์€ 93.41์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 2.18์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -72.19์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -66.27์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -59.29์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -75.25์ž…๋‹ˆ๋‹ค.

EyePoint Pharmaceuticals Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
EyePoint Pharmaceuticals Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -243.43M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -66.90์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ